To our knowledge, the current study is the first to report the beneficial effects of anti-SEMA4D antibody in preventing and improving the symptoms and deficits in a transgenic mouse model of Rett syndrome. The gene discussed is SEMA4D; the disease is atypical Rett syndrome.